MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q4
hinzugefügt 03.02.2026
Land |
 Vereinigte Staaten |
IPO-Jahr |
- |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ CAPITAL |
Anteile |
6.28 M |
Marktkapitalisierung |
$ 16.6 M |
EBITDA (LTM) |
$ -1.64 M |
P/E (LTM) |
-42.17 |
P/S (LTM) |
0.25 |
EPS (LTM) |
-0.06 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Alterity Therapeutics Limited
ATHE
|
$ 3.6 | 4.96 % | $ 8.66 B | Nasdaq Capital Market |  Australia |
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market |  Germany |
 |
Atara Biotherapeutics
ATRA
|
$ 6.88 | 33.08 % | $ 51.5 M | Nasdaq Global Select Market,SPB | USA |
 |
BridgeBio Pharma
BBIO
|
$ 65.8 | 0.67 % | $ 12.6 B | Nasdaq Global Select Market,SPB | USA |
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | USA |
 |
AbCellera Biologics
ABCL
|
$ 3.52 | 1.88 % | $ 1.05 B | Nasdaq Global Select Market |  Canada |
 |
Biogen
BIIB
|
$ 187.79 | 1.5 % | $ 27.5 B | Nasdaq Global Select Market,SPB | USA |
 |
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market |  China |
 |
Benitec Biopharma
BNTC
|
$ 12.61 | 11.02 % | $ 519 M | Nasdaq Capital Market | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
BioXcel Therapeutics
BTAI
|
$ 1.76 | 18.92 % | $ 4.46 M | Nasdaq Global Select Market,SPB | USA |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market |  France |
 |
Burford Capital Limited
BUR
|
$ 8.25 | 6.25 % | $ 1.31 B | NYSE |  Britain |
 |
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | USA |
 |
BeyondSpring
BYSI
|
$ 1.46 | 0.92 % | $ 58.9 M | Nasdaq Capital Market | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
Annovis Bio
ANVS
|
$ 2.57 | 3.63 % | $ 23.2 M | NYSE American | USA |
 |
Cabaletta Bio
CABA
|
$ 3.29 | 3.63 % | $ 3.84 M | Nasdaq Global Select Market | USA |
 |
Catalyst Biosciences
CBIO
|
$ 12.08 | 0.04 % | $ 795 M | Nasdaq Capital Market | USA |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market | Britain |
 |
C4 Therapeutics
CCCC
|
$ 3.54 | 16.28 % | $ 293 M | Nasdaq Global Select Market | USA |
 |
Alpine Immune Sciences
ALPN
|
- | - | $ 2.17 B | Nasdaq Global Market | USA |
 |
AlloVir
ALVR
|
- | 4.14 % | $ 49.1 M | Nasdaq Global Select Market | USA |
 |
Codexis
CDXS
|
$ 1.27 | 3.25 % | $ 93.2 M | Nasdaq Global Select Market | USA |
 |
Cerus Corporation
CERS
|
$ 1.95 | 0.78 % | $ 372 M | Nasdaq Global Market | USA |
 |
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | USA |
 |
Cullinan Management
CGEM
|
$ 15.42 | -2.03 % | $ 902 M | Nasdaq Global Select Market | USA |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
Coherus BioSciences
CHRS
|
$ 1.93 | 5.77 % | $ 182 M | Nasdaq Global Market | USA |
 |
ADC Therapeutics SA
ADCT
|
$ 4.15 | 1.22 % | $ 105 M | NYSE |  Schweiz |
 |
Acer Therapeutics
ACER
|
- | 2.71 % | $ 14 M | Nasdaq Capital Market | USA |
 |
ARCA biopharma
ABIO
|
- | 1052.0 % | $ 415 M | Nasdaq Capital Market | USA |
 |
Celldex Therapeutics
CLDX
|
$ 31.55 | 7.2 % | $ 2.1 B | Nasdaq Global Select Market | USA |
 |
Cellectis S.A.
CLLS
|
$ 3.59 | 0.7 % | $ 116 M | Nasdaq Global Market | France |
 |
Aeterna Zentaris
AEZS
|
- | 5.93 % | $ 314 M | Nasdaq Capital Market | Canada |
 |
Cellectar Biosciences
CLRB
|
$ 2.87 | 3.99 % | $ 7.49 M | Nasdaq Capital Market | USA |
 |
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | USA |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
Acasti Pharma
ACST
|
- | 4.01 % | $ 150 M | Nasdaq Capital Market | Canada |
 |
Collegium Pharmaceutical
COLL
|
$ 37.35 | 0.15 % | $ 1.18 B | Nasdaq Global Select Market | USA |
 |
Ampio Pharmaceuticals
AMPE
|
- | -11.43 % | $ 502 K | NYSE American | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
$ 33.98 | 0.32 % | $ 3.53 B | Nasdaq Capital Market,SPB | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
$ 24.73 | 2.02 % | $ 3.02 B | Nasdaq Capital Market | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
$ 9.56 | 19.35 % | $ 41.4 M | Nasdaq Global Market | USA |
 |
Applied Therapeutics
APLT
|
- | - | $ 8.42 M | Nasdaq Global Market,SPB | USA |
 |
CureVac N.V.
CVAC
|
- | - | $ 867 M | Nasdaq Global Market | Germany |
 |
Atea Pharmaceuticals
AVIR
|
$ 6.14 | 4.16 % | $ 500 M | Nasdaq Global Select Market | USA |
 |
Cardiff Oncology
CRDF
|
$ 2.01 | 6.65 % | $ 134 M | Nasdaq Capital Market | USA |